HK1198326A1 - 用於預防或治療上呼吸道感染的鼠李糖乳桿菌和動物雙歧桿菌乳亞種 - Google Patents

用於預防或治療上呼吸道感染的鼠李糖乳桿菌和動物雙歧桿菌乳亞種

Info

Publication number
HK1198326A1
HK1198326A1 HK14111845.8A HK14111845A HK1198326A1 HK 1198326 A1 HK1198326 A1 HK 1198326A1 HK 14111845 A HK14111845 A HK 14111845A HK 1198326 A1 HK1198326 A1 HK 1198326A1
Authority
HK
Hong Kong
Prior art keywords
lactis
prevention
treatment
respiratory tract
upper respiratory
Prior art date
Application number
HK14111845.8A
Other languages
English (en)
Inventor
Tracey Jane Smith
Original Assignee
Chr Hansen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47664241&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1198326(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chr Hansen As filed Critical Chr Hansen As
Publication of HK1198326A1 publication Critical patent/HK1198326A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK14111845.8A 2012-01-13 2014-11-24 用於預防或治療上呼吸道感染的鼠李糖乳桿菌和動物雙歧桿菌乳亞種 HK1198326A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12151148 2012-01-13
PCT/EP2013/050552 WO2013104783A1 (en) 2012-01-13 2013-01-14 Lactobacillus rhamnosus and bifidobacterium animalis subsp. lactis for use in prevention or treatment of upper respiratory tract infections

Publications (1)

Publication Number Publication Date
HK1198326A1 true HK1198326A1 (zh) 2015-04-02

Family

ID=47664241

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14111845.8A HK1198326A1 (zh) 2012-01-13 2014-11-24 用於預防或治療上呼吸道感染的鼠李糖乳桿菌和動物雙歧桿菌乳亞種

Country Status (8)

Country Link
US (2) US9642883B2 (zh)
EP (1) EP2802333B1 (zh)
CN (1) CN104080465A (zh)
DK (1) DK2802333T3 (zh)
ES (1) ES2795976T3 (zh)
HK (1) HK1198326A1 (zh)
PL (1) PL2802333T3 (zh)
WO (1) WO2013104783A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111154693A (zh) * 2020-01-21 2020-05-15 北京科拓恒通生物技术股份有限公司 一株可改善上呼吸道感染症的鼠李糖乳杆菌Probio-M9及其应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104080465A (zh) * 2012-01-13 2014-10-01 科.汉森有限公司 用于预防或治疗上呼吸道感染的鼠李糖乳杆菌和动物双歧杆菌乳亚种
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
JP6414487B2 (ja) * 2015-02-27 2018-10-31 オムロンヘルスケア株式会社 喘鳴関連情報表示装置
FR3062287B1 (fr) * 2017-01-27 2021-07-16 Denali Pharma Composition probiotique nutritionnelle et utilisation d'une telle composition pour la fabrication d'un supplement de probiotiques
CN107213338A (zh) * 2017-07-19 2017-09-29 颐和益生（北京）科技有限公司 一种具有预防呼吸道感染的抗雾霾组合物、制备方法及应用
US11229673B2 (en) 2019-05-10 2022-01-25 Société des Produits Nestlé S.A. Methods for improving the quality of life of a patient with a peanut allergy
CN114480229B (zh) * 2022-04-15 2022-08-09 微康益生菌(苏州)股份有限公司 一种动物双歧杆菌乳亚种菌株wkb148及其产品与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
ITMI20042189A1 (it) 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
CN104080465A (zh) * 2012-01-13 2014-10-01 科.汉森有限公司 用于预防或治疗上呼吸道感染的鼠李糖乳杆菌和动物双歧杆菌乳亚种

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111154693A (zh) * 2020-01-21 2020-05-15 北京科拓恒通生物技术股份有限公司 一株可改善上呼吸道感染症的鼠李糖乳杆菌Probio-M9及其应用

Also Published As

Publication number Publication date
EP2802333B1 (en) 2020-03-11
DK2802333T3 (da) 2020-03-23
PL2802333T3 (pl) 2020-09-07
EP2802333A1 (en) 2014-11-19
US10286018B2 (en) 2019-05-14
US9642883B2 (en) 2017-05-09
WO2013104783A1 (en) 2013-07-18
US20170258856A1 (en) 2017-09-14
CN104080465A (zh) 2014-10-01
ES2795976T3 (es) 2020-11-25
US20150118190A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
HK1198326A1 (zh) 用於預防或治療上呼吸道感染的鼠李糖乳桿菌和動物雙歧桿菌乳亞種
HK1226100B (zh) 雙歧桿菌乳酸亞種(bifidobacterium animalis subsp．lactis)cect 8145的新菌株及其用於治療和/或預防超重和肥胖症以及相關疾病的用途
HK1213805A1 (zh) 益生生物和/或治療劑的靶向胃腸道遞送
IL226212A0 (en) Probiotics are non-replicating microorganisms for protection against inflammation in the upper respiratory tract
PL3681470T3 (pl) Lactobacillus casei lub lactobacillus paracasei do stosowania w leczeniu infekcji clostridium difficile
RS63856B1 (sr) Probiotički sojevi bakterija za prevenciju i lečenje bolesti u usnoj duplji
HK1204869A1 (zh) 用於預防和治療感染的益生菌來源的無活力的材料
HK1200116A1 (zh) 用作用於營養和醫藥應用的益生菌劑的細菌
MX2015007971A (es) Utilizacion de bifidobacterium animalis para el tratamiento o la prevencion de la ganancia de peso corporal y de la resistencia a la insulina.
PL2364712T3 (pl) Miejscowa kompozycja kosmetyczna lub farmaceutyczna zawierająca probiotyczne szczepy pałeczek bakterii kwasu mlekowego i jej stosowanie
PL2457576T3 (pl) Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
IL222333A0 (en) Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract
EP2796142A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING DEATH CELLS OF LACTOBACILLUS ACIDOPHILUS LB STRAIN FOR THE TREATMENT OR PREVENTION OF ALLERGIC DISEASE
PL2568815T3 (pl) Fermentacja synergistyczna lactobacillus rhamnosus i lactobacillus paracasei podgatunek paracasei
LT2854826T (lt) Lactobacillus reuteri atcc pta 6475, skirtas panaudoti kaulų masės praradimo prevencijai arba gydymui žinduoliuose
EP2923704A4 (en) AID FOR RESTRICTING STRESS-RELATED ENTREPRISING DISEASE WITH A SPECIFIC LACTOBACILLUS GASSERI TRIBE OR A TREATMENT PRODUCT THEREOF
HK1146914A1 (en) Pharmaceutical compositions comprising l. acidophilus and bifidobacterium lactis for use in the treatment of functional bowel disorder
SG11201504542PA (en) Probiotic strains for the treatment and/or prevention of diarrhœa
HUE062482T2 (hu) Lactobacillus reuteri- és citráttartalmú készítmény gyógyászati felhasználásra
WO2014096083A3 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine
ZA201303631B (en) Detection and/or diagnosis of mite infections in sheep
RS20100436A3 (en) Indigenous LACTOBACILLUS strains and their use as probiotics
PL397178A1 (pl) Kompozycja probiotyczna